Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection.

Önnheim K, Ekblad M, Görander S, Bergström T, Liljeqvist JÅ.

Viruses. 2016 Apr 22;8(4):110. doi: 10.3390/v8040110.

2.

The Cholestanol-Conjugated Sulfated Oligosaccharide PG545 Disrupts the Lipid Envelope of Herpes Simplex Virus Particles.

Said JS, Trybala E, Görander S, Ekblad M, Liljeqvist JÅ, Jennische E, Lange S, Bergström T.

Antimicrob Agents Chemother. 2015 Dec 7;60(2):1049-57. doi: 10.1128/AAC.02132-15. Print 2016 Feb.

3.

Novel rat models to study primary genital herpes simplex virus-2 infection.

Önnheim K, Ekblad M, Görander S, Lange S, Jennische E, Bergström T, Wildt S, Liljeqvist JÅ.

Arch Virol. 2015 May;160(5):1153-61. doi: 10.1007/s00705-015-2365-7. Epub 2015 Feb 21.

PMID:
25701211
5.

Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease.

Görander S, Harandi AM, Lindqvist M, Bergström T, Liljeqvist JÅ.

J Virol. 2012 Jul;86(14):7544-53. doi: 10.1128/JVI.00186-12. Epub 2012 May 2.

6.

Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.

Görander S, Lagergård T, Romanik M, Viscidi RP, Martirosian G, Liljeqvist JA.

Clin Vaccine Immunol. 2008 Apr;15(4):675-80. doi: 10.1128/CVI.00260-07. Epub 2008 Feb 20.

7.

Real-time Taqman PCR targeting 14 human papilloma virus types.

Lindh M, Görander S, Andersson E, Horal P, Mattsby-Balzer I, Ryd W.

J Clin Virol. 2007 Dec;40(4):321-4. Epub 2007 Nov 5.

PMID:
17981499
8.

Multiphasic encephalomyelitis in a patient with recurrent herpes simplex type 2 meningitis.

Görander S, Andersen O, Leiram B, Franzén C, Bergström T.

Scand J Infect Dis. 2006;38(10):942-5.

PMID:
17008246
9.

Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.

Görander S, Mbwana J, Lyamuya E, Lagergård T, Liljeqvist JA.

Clin Vaccine Immunol. 2006 Jun;13(6):633-9.

10.

CD4(+) T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals.

Eriksson K, Bellner L, Görander S, Löwhagen GB, Tunbäck P, Rydberg K, Liljeqvist JA.

J Gen Virol. 2004 Aug;85(Pt 8):2139-47.

PMID:
15269352
11.

Supplemental Content

Loading ...
Support Center